Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mesenchymal stem cells in infantile haemangioma.
Itinteang T, Vishvanath A, Day DJ, Tan ST. Itinteang T, et al. Among authors: vishvanath a. J Clin Pathol. 2011 Mar;64(3):232-6. doi: 10.1136/jcp.2010.085209. Epub 2011 Jan 17. J Clin Pathol. 2011. PMID: 21242328
Primitive erythropoiesis in infantile haemangioma.
Itinteang T, Tan ST, Brasch HD, Vishvanath A, Day DJ. Itinteang T, et al. Among authors: vishvanath a. Br J Dermatol. 2011 May;164(5):1097-100. doi: 10.1111/j.1365-2133.2010.10187.x. Br J Dermatol. 2011. PMID: 21518328
Infantile haemangioma expresses embryonic stem cell markers.
Itinteang T, Tan ST, Brasch HD, Steel R, Best HA, Vishvanath A, Jia J, Day DJ. Itinteang T, et al. Among authors: vishvanath a. J Clin Pathol. 2012 May;65(5):394-8. doi: 10.1136/jclinpath-2011-200462. Epub 2012 Mar 23. J Clin Pathol. 2012. PMID: 22447921
High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4).
Cheung L, Flemming CL, Watt F, Masada N, Yu DM, Huynh T, Conseil G, Tivnan A, Polinsky A, Gudkov AV, Munoz MA, Vishvanath A, Cooper DM, Henderson MJ, Cole SP, Fletcher JI, Haber M, Norris MD. Cheung L, et al. Among authors: vishvanath a. Biochem Pharmacol. 2014 Sep 1;91(1):97-108. doi: 10.1016/j.bcp.2014.05.023. Epub 2014 Jun 25. Biochem Pharmacol. 2014. PMID: 24973542
Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3.
Bali P, George P, Cohen P, Tao J, Guo F, Sigua C, Vishvanath A, Scuto A, Annavarapu S, Fiskus W, Moscinski L, Atadja P, Bhalla K. Bali P, et al. Among authors: vishvanath a. Clin Cancer Res. 2004 Aug 1;10(15):4991-7. doi: 10.1158/1078-0432.CCR-04-0210. Clin Cancer Res. 2004. PMID: 15297399